Spark Investment Management’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
Other funds holding LRMR
DM
CA
RCM
O
VC
ACP
SFM
SCM
AVA
6CM
Spark Investment Management's LRMR Position: Q2 2020 in Review
Spark Investment Management sold out of Larimar Therapeutics (LRMR) in Q2 2020, closing a stake of 948 shares — an estimated $8K sold.
Spark Investment Management first reported a position in LRMR in Q3 2014 and held it in 18 quarters. The position peaked at $4.02M in Q1 2015. 37 funds tracked by Wall St. Rank hold LRMR as of Q2 2020.
- Spark Investment Management reported no remaining Larimar Therapeutics position as of Q2 2020 after selling out during the quarter.
- Spark Investment Management sold 948 Larimar Therapeutics shares in Q2 2020, an estimated $8K.
- Spark Investment Management first reported a position in Larimar Therapeutics in Q3 2014 and held it in 18 quarters.
- Spark Investment Management's Larimar Therapeutics position peaked at $4.02M in Q1 2015.
- 37 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2020.
Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.